{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:45:13Z","timestamp":1794451513491,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"25","license":[{"start":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T00:00:00Z","timestamp":1319414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T00:00:00Z","timestamp":1319414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,6,21]]},"DOI":"10.1038\/onc.2011.475","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T10:58:46Z","timestamp":1319453926000},"page":"3098-3110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma"],"prefix":"10.1038","volume":"31","author":[{"given":"T","family":"Kanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kanematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,24]]},"reference":[{"key":"BFonc2011475_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill F . (2004). Cancer and the chemokine network. Nat Rev Cancer 4: 540\u2013550.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011475_CR2","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1128\/MCB.17.11.6330","volume":"17","author":"J Bian","year":"1997","unstructured":"Bian J, Sun Y . (1997). Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17: 6330\u20136338.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011475_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1056\/NEJMe068263","volume":"356","author":"J Brugarolas","year":"2007","unstructured":"Brugarolas J . (2007). Renal-cell carcinoma\u2014molecular pathways and therapies. N Engl J Med 356: 185\u2013187.","journal-title":"N Engl J Med"},{"key":"BFonc2011475_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12094-010-0485-9","volume":"12","author":"MJ Calzada","year":"2010","unstructured":"Calzada MJ . (2010). von Hippel\u2013Lindau syndrome: molecular mechanisms of the disease. Clin Transl Oncol 12: 160\u2013165.","journal-title":"Clin Transl Oncol"},{"key":"BFonc2011475_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF . (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859\u2013868.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011475_CR6","doi-asserted-by":"publisher","first-page":"pe30","DOI":"10.1126\/scisignal.124pe30","volume":"1","author":"IJ Frew","year":"2008","unstructured":"Frew IJ, Krek W . (2008). pVHL: a multipurpose adaptor protein. Sci Signal 1: pe30.","journal-title":"Sci Signal"},{"key":"BFonc2011475_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0002-9440(10)63887-4","volume":"162","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ et al. (2003). Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 162: 925\u2013932.","journal-title":"Am J Pathol"},{"key":"BFonc2011475_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin Jr WG . (2008). The von Hippel\u2013Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8: 865\u2013873.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011475_CR9","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/cncr.24232","volume":"115","author":"WG Kaelin Jr","year":"2009","unstructured":"Kaelin Jr WG . (2009). Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein. Cancer 115: 2262\u20132272.","journal-title":"Cancer"},{"key":"BFonc2011475_CR10","first-page":"3113","volume":"7","author":"BV Kallakury","year":"2001","unstructured":"Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS . (2001). Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7: 3113\u20133119.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011475_CR11","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1161\/ATVBAHA.108.162925","volume":"28","author":"EC Keeley","year":"2008","unstructured":"Keeley EC, Mehrad B, Strieter RM . (2008). Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol 28: 1928\u20131936.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFonc2011475_CR12","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","volume":"1","author":"K Kondo","year":"2003","unstructured":"Kondo K, Kim WY, Lechpammer M, Kaelin Jr WG . (2003). Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol 1: E83.","journal-title":"PLoS Biol"},{"key":"BFonc2011475_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","volume":"1","author":"K Kondo","year":"2002","unstructured":"Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin Jr WG . (2002). Inhibition of HIF is necessary for tumor suppression by the von Hippel\u2013Lindau protein. Cancer Cell 1: 237\u2013246.","journal-title":"Cancer Cell"},{"key":"BFonc2011475_CR14","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1128\/MCB.19.9.5902","volume":"19","author":"S Koochekpour","year":"1999","unstructured":"Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM et al. (1999). The von Hippel\u2013Lindau tumor suppressor gene inhibits hepatocyte growth factor\/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol 19: 5902\u20135912.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011475_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.onc.1210709","volume":"27","author":"G Kurban","year":"2008","unstructured":"Kurban G, Duplan E, Ramlal N, Hudon V, Sado Y, Ninomiya Y et al. (2008). Collagen matrix assembly is driven by the interaction of von Hippel\u2013Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2. Oncogene 27: 1004\u20131012.","journal-title":"Oncogene"},{"key":"BFonc2011475_CR16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-05-2560","volume":"66","author":"G Kurban","year":"2006","unstructured":"Kurban G, Hudon V, Duplan E, Ohh M, Pause A . (2006). Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis. Cancer Res 66: 1313\u20131319.","journal-title":"Cancer Res"},{"key":"BFonc2011475_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1083\/jcb.200409115","volume":"169","author":"S Lee","year":"2005","unstructured":"Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML . (2005a). Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169: 681\u2013691.","journal-title":"J Cell Biol"},{"key":"BFonc2011475_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","volume":"8","author":"S Lee","year":"2005","unstructured":"Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP et al. (2005b). Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8: 155\u2013167.","journal-title":"Cancer Cell"},{"key":"BFonc2011475_CR19","doi-asserted-by":"publisher","first-page":"671s","DOI":"10.1158\/1078-0432.CCR-06-1870","volume":"13","author":"WM Linehan","year":"2007","unstructured":"Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L et al. (2007). Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res 13: 671s\u2013679s.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011475_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ccr.2004.09.006","volume":"6","author":"WM Linehan","year":"2004","unstructured":"Linehan WM, Zbar B . (2004). Focus on kidney cancer. Cancer Cell 6: 223\u2013228.","journal-title":"Cancer Cell"},{"key":"BFonc2011475_CR21","doi-asserted-by":"publisher","first-page":"29087","DOI":"10.1074\/jbc.M109.035899","volume":"284","author":"X Lu","year":"2009","unstructured":"Lu X, Kang Y . (2009). Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem 284: 29087\u201329096.","journal-title":"J Biol Chem"},{"key":"BFonc2011475_CR22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/eji.1830270508","volume":"27","author":"T Martin","year":"1997","unstructured":"Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR . (1997). Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol 27: 1091\u20131097.","journal-title":"Eur J Immunol"},{"key":"BFonc2011475_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271\u2013275.","journal-title":"Nature"},{"key":"BFonc2011475_CR24","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/onc.2009.493","volume":"29","author":"MR Morris","year":"2010","unstructured":"Morris MR, Ricketts C, Gentle D, Abdulrahman M, Clarke N, Brown M et al. (2010). Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene 29: 2104\u20132117.","journal-title":"Oncogene"},{"key":"BFonc2011475_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2353\/ajpath.2006.050867","volume":"168","author":"E Nakamura","year":"2006","unstructured":"Nakamura E, Abreu-e-Lima P, Awakura Y, Inoue T, Kamoto T, Ogawa O et al. (2006). Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel\u2013Lindau tumor suppressor protein. Am J Pathol 168: 574\u2013584.","journal-title":"Am J Pathol"},{"key":"BFonc2011475_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/EP:17:2:97","volume":"17","author":"E Nakamura","year":"2006","unstructured":"Nakamura E, Kaelin Jr WG . (2006). Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma. Endocr Pathol 17: 97\u2013106.","journal-title":"Endocr Pathol"},{"key":"BFonc2011475_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","volume":"1","author":"M Ohh","year":"1998","unstructured":"Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN et al. (1998). The von Hippel\u2013Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1: 959\u2013968.","journal-title":"Mol Cell"},{"key":"BFonc2011475_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.onc.1209759","volume":"26","author":"BW Ozanne","year":"2007","unstructured":"Ozanne BW, Spence HJ, McGarry LC, Hennigan RF . (2007). Transcription factors control invasion: AP-1 the first among equals. Oncogene 26: 1\u201310.","journal-title":"Oncogene"},{"key":"BFonc2011475_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ng790","volume":"30","author":"E Passegue","year":"2002","unstructured":"Passegue E, Jochum W, Behrens A, Ricci R, Wagner EF . (2002). JunB can substitute for Jun in mouse development and cell proliferation. Nat Genet 30: 158\u2013166.","journal-title":"Nat Genet"},{"key":"BFonc2011475_CR30","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/sj.bjc.6605409","volume":"101","author":"JL Perez-Gracia","year":"2009","unstructured":"Perez-Gracia JL, Prior C, Guillen-Grima F, Segura V, Gonzalez A, Panizo A et al. (2009). Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer 101: 1876\u20131883.","journal-title":"Br J Cancer"},{"key":"BFonc2011475_CR31","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1042\/BST0360864","volume":"36","author":"M Piechaczyk","year":"2008","unstructured":"Piechaczyk M, Farras R . (2008). Regulation and function of JunB in cell proliferation. Biochem Soc Trans 36: 864\u2013867.","journal-title":"Biochem Soc Trans"},{"key":"BFonc2011475_CR32","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","volume":"10","author":"BI Rini","year":"2009","unstructured":"Rini BI, Atkins MB . (2009). Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 10: 992\u20131000.","journal-title":"Lancet Oncol"},{"key":"BFonc2011475_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B . (2009). Renal cell carcinoma. Lancet 373: 1119\u20131132.","journal-title":"Lancet"},{"key":"BFonc2011475_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/CCO.0b013e3282f310de","volume":"20","author":"AM Roberts","year":"2008","unstructured":"Roberts AM, Ohh M . (2008). Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel\u2013Lindau. Curr Opin Oncol 20: 83\u201389.","journal-title":"Curr Opin Oncol"},{"key":"BFonc2011475_CR35","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","volume":"27","author":"R Roy","year":"2009","unstructured":"Roy R, Yang J, Moses MA . (2009). Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287\u20135297.","journal-title":"J Clin Oncol"},{"key":"BFonc2011475_CR36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.V96.1.34","volume":"96","author":"R Salcedo","year":"2000","unstructured":"Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK et al. (2000). Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34\u201340.","journal-title":"Blood"},{"key":"BFonc2011475_CR37","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.emboj.7601539","volume":"26","author":"D Schmidt","year":"2007","unstructured":"Schmidt D, Textor B, Pein OT, Licht AH, Andrecht S, Sator-Schmitt M et al. (2007). Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis. EMBO J 26: 710\u2013719.","journal-title":"EMBO J"},{"key":"BFonc2011475_CR38","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cellsig.2009.12.008","volume":"22","author":"E Shaulian","year":"2010","unstructured":"Shaulian E . (2010). AP-1\u2014the Jun proteins: oncogenes or tumor suppressors in disguise? Cell Signal 22: 894\u2013899.","journal-title":"Cell Signal"},{"key":"BFonc2011475_CR39","doi-asserted-by":"publisher","first-page":"10487","DOI":"10.1158\/0008-5472.CAN-06-1461","volume":"66","author":"H Song","year":"2006","unstructured":"Song H, Ki SH, Kim SG, Moon A . (2006). Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res 66: 10487\u201310496.","journal-title":"Cancer Res"},{"key":"BFonc2011475_CR40","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1182\/blood-2007-02-071258","volume":"110","author":"PB Staber","year":"2007","unstructured":"Staber PB, Vesely P, Haq N, Ott RG, Funato K, Bambach I et al. (2007). The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1\/2 and JunB translation via mTOR signaling. Blood 110: 3374\u20133383.","journal-title":"Blood"},{"key":"BFonc2011475_CR41","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/path.2310","volume":"214","author":"K Struckmann","year":"2008","unstructured":"Struckmann K, Mertz K, Steu S, Storz M, Staller P, Krek W et al. (2008). pVHL coordinately regulates CXCR4\/CXCL12 and MMP2\/MMP9 expression in human clear-cell renal cell carcinoma. J Pathol 214: 464\u2013471.","journal-title":"J Pathol"},{"key":"BFonc2011475_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1046\/j.1442-2042.2002.00516.x","volume":"9","author":"M Takahashi","year":"2002","unstructured":"Takahashi M, Oka N, Naroda T, Nishitani MA, Kanda K, Kanayama HO et al. (2002). Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma. Int J Urol 9: 531\u2013538.","journal-title":"Int J Urol"},{"key":"BFonc2011475_CR43","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1158\/0008-5472.CAN-09-2984","volume":"70","author":"N Terada","year":"2010","unstructured":"Terada N, Shimizu Y, Kamba T, Inoue T, Maeno A, Kobayashi T et al. (2010). Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer Res 70: 1606\u20131615.","journal-title":"Cancer Res"},{"key":"BFonc2011475_CR44","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1158\/0008-5472.CAN-05-0925","volume":"65","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Sasaki M, Itoh K, Higashihara M, Umezawa K, Kadin ME et al. (2005). JunB induced by constitutive CD30-extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and Reed\u2013Sternberg cells of Hodgkin lymphoma. Cancer Res 65: 7628\u20137634.","journal-title":"Cancer Res"},{"key":"BFonc2011475_CR45","first-page":"9","volume":"147","author":"N Weidner","year":"1995","unstructured":"Weidner N . (1995). Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9\u201319.","journal-title":"Am J Pathol"},{"key":"BFonc2011475_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1677\/erc.1.00683","volume":"13","author":"ER Woodward","year":"2006","unstructured":"Woodward ER, Maher ER . (2006). von Hippel\u2013Lindau disease and endocrine tumour susceptibility. Endocr Relat Cancer 13: 415\u2013425.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2011475_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2007.09.010","volume":"28","author":"H Yang","year":"2007","unstructured":"Yang H, Minamishima YA, Yan Q, Schlisio S, Ebert BL, Zhang X et al. (2007). pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell 28: 15\u201327.","journal-title":"Mol Cell"},{"key":"BFonc2011475_CR48","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1158\/1078-0432.CCR-09-2131","volume":"15","author":"AC Young","year":"2009","unstructured":"Young AC, Craven RA, Cohen D, Taylor C, Booth C, Harnden P et al. (2009). Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma. Clin Cancer Res 15: 7582\u20137592.","journal-title":"Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011475","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:33:21Z","timestamp":1647887601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,24]]},"references-count":48,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2012,6,21]]}},"alternative-id":["BFonc2011475"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.475","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,24]]},"assertion":[{"value":"22 December 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}